Skip to main content

Log In Create an account

Products & Services
Back
Explore
- About Our Products & Services
- Our Tests
  Back
  Our Tests
  
  Compare Our Tests
  
  FoundationOne CDx
  
  FoundationOne Liquid CDx
  
  FoundationOne Heme
  
  PD-L1 IHC Testing
- Provider Services
  Back
  Provider Services
  
  Overview
  
  Online Ordering & Report Integrations
  
  Clinical Research & Trial Matching
  
  Decision Support & Provider Education
- Biopharma Partner Services
  Back
  Biopharma Partner Services
  
  Overview
  
  Genomic Data Solutions
  
  Clinical Trial Solutions
  
  Companion Diagnostic Development & Commercialization
- Actionable Results
Latest CDx Indication

FoundationOne®Liquid CDx has been approved by the FDA as the only blood-based comprehensive genomic profiling (CGP) companion diagnostic (CDx) for Tabrecta® (capmatinib).
Resource Center
Back
Explore
Latest CDx Indication

FoundationOne®Liquid CDx has been approved by the FDA as the only blood-based comprehensive genomic profiling (CGP) companion diagnostic (CDx) for Tabrecta® (capmatinib).
News & Events
Back
Explore
Useful Information
Join us at AUA 2021

Foundation Medicine will attend the virtual American Urological Association Annual Meeting September 10-13, 2021. | Learn more
About Us
Back
About Us
Useful Information
Careers
For Patients
Order a Test

Press Releases

View

News & Events Overview
Press Releases
Blog
Events
Media Library

Products & Services
Our Tests
Provider Services
Biopharma Partner Services

News & Events
Press Releases
Blog
Events

About Us
Our Story
Leadership Team
Careers

Contact Us
Login
Order a Test

© 2021 FOUNDATION MEDICINE, INC.

Legal & Privacy
California Compliance
Notice of Privacy Practices
Licenses
Update Cookie Preferences